Healthcare & Life Sciences
TRACON Pharmaceuticals
United States
alivepre-ipo
pre-ipo
Stage
1
Investors
About
TRACON Pharmaceuticals is a clinical stage biopharmaceutical company developing novel therapeutics for cancer and age-related macular degeneration.
Explore TRACON Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.